Hypercholesterolaemia
Not yet recruitingEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
Effect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
- Disease:Hypercholesterolaemia
- Substances:Rosuvastatin
Germany- Participants:18–64 years · 65+ years
- Substances:Rosuvastatin
- Sponsor:AstraZeneca AB



